SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-15-024173
Filing Date
2015-03-31
Accepted
2015-03-31 06:04:31
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a15-8010_110k.htm 10-K 2389416
2 EX-2.1 a15-8010_1ex2d1.htm EX-2.1 47597
3 EX-2.2 a15-8010_1ex2d2.htm EX-2.2 208067
4 EX-4.2 a15-8010_1ex4d2.htm EX-4.2 99098
5 EX-4.3 a15-8010_1ex4d3.htm EX-4.3 151019
6 EX-10.8 a15-8010_1ex10d8.htm EX-10.8 1727006
7 EX-10.16 a15-8010_1ex10d16.htm EX-10.16 397140
8 EX-23.1 a15-8010_1ex23d1.htm EX-23.1 2774
9 EX-31.1 a15-8010_1ex31d1.htm EX-31.1 11109
10 EX-31.2 a15-8010_1ex31d2.htm EX-31.2 11153
11 EX-32.1 a15-8010_1ex32d1.htm EX-32.1 4927
12 EX-32.2 a15-8010_1ex32d2.htm EX-32.2 4894
13 GRAPHIC g80101bki001.jpg GRAPHIC 14755
14 GRAPHIC g80101mq09ai001.jpg GRAPHIC 3167
15 GRAPHIC g80101mq09ai002.jpg GRAPHIC 3169
16 GRAPHIC g80101mq13ai001.jpg GRAPHIC 26522
17 GRAPHIC g80101mq13ai002.jpg GRAPHIC 12758
  Complete submission text file 0001104659-15-024173.txt   5139214
Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36845 | Film No.: 15736329
SIC: 2834 Pharmaceutical Preparations